论文部分内容阅读
应用干扰素治疗各种病毒性疾病近年来很受重视。本文作者用人类白细胞干扰素的商品制剂(每毫升含生物效价64单位)及其诱导物(聚乙稀吡洛烷酮)治疗病毒性肺炎取得了显著的疗效。
The application of interferon in the treatment of various viral diseases has drawn great attention in recent years. The authors achieved a significant therapeutic effect in the treatment of viral pneumonia with commercial preparations of human leukocyte interferon (64 units per milliliter of biological potency) and its inducer (polyvinylpyrrolidone).